Your browser doesn't support javascript.
loading
Case Report: Post-transplant lymphoproliferative disorder as a serious complication of vascularized composite allotransplantation.
Zaccardelli, Alessandra; Lucas, Fabienne M; LaCasce, Ann S; Chandraker, Anil K; Azzi, Jamil R; Talbot, Simon G.
Afiliação
  • Zaccardelli A; Department of Medical Education, Tufts University School of Medicine, Boston, MA, United States.
  • Lucas FM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.
  • LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
  • Chandraker AK; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
  • Azzi JR; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
  • Talbot SG; Division of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Boston, MA, United States.
Front Transplant ; 3: 1339898, 2024.
Article em En | MEDLINE | ID: mdl-38993757
ABSTRACT
Vascularized composite allotransplantation (VCA) is an emerging field in transplant surgery. Despite overall positive outcomes, VCA confers risk for multiple complications related to the procedure and subsequent immunosuppression. Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of lymphoproliferative disorders occurring after solid organ and hematopoietic stem cell transplant. A patient with PTLD after bilateral upper extremity transplantation is presented as well as a review of all known cases of PTLD after VCA, with a focus on the unique epidemiology, presentation, and treatment in this population.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article